Takashina, Yoshiaki <br/><br/>
Impact of CYP3A5 and ABCB1 gene polymorphisms on fentanyl pharmacokinetics and clinical responses in cancer patients undergoing conversion to a transdermal system.  [electronic resource] 

 -  Drug metabolism and pharmacokinetics  2012 
 - 414-21 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1880-0920 
<br/><br/><label>Standard No.: </label>10.2133/dmpk.dmpk-11-rg-134  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ATP Binding Cassette Transporter, Subfamily B<br/>ATP Binding Cassette Transporter, Subfamily B, Member 1--genetics<br/>Administration, Cutaneous<br/>Aged<br/>Analgesics, Opioid--administration & dosage<br/>Cytochrome P-450 CYP3A--genetics<br/>Drug Monitoring<br/>Female<br/>Fentanyl--administration & dosage<br/>Genotype<br/>Humans<br/>Japan<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Odds Ratio<br/>Pharmacogenetics<br/>Phenotype<br/>Polymorphism, Genetic